港股異動丨績後獲多家機構唱好,普拉達續升超6%創逾一個月新高
普拉達(1913.HK)再度拉昇升超6%,股價重回60港元關口且創超一個月新高,總市值1521億港元。公司日前發佈公吿,截至6月30日止中期純利約3.8億元(歐元.下同),同比升約25.7%,每股盈利0.15元,不派中期股息。績後公司獲多家大行唱好。麥格理升普拉達目標價至70元,上半年業績穩固;瑞銀予普拉達73.5港元目標價及“買入”評級,盈利動能強勁;中金維持普拉達“跑贏大市”評級,目標價75港元,指其上半年業績超出預期。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.